Mechanism of EGF-Mediated Reduction of NEC
EGF 介导的 NEC 减少机制
基本信息
- 批准号:7467939
- 负责人:
- 金额:$ 29.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-02-15 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcidsAffectApoptosisApoptoticBile AcidsBile fluidBreast FeedingCell LineCellsConditionDataDevelopmentDiseaseDistalDistal part of ileumDoseDuodenumEnterocolitisEnterohepatic CirculationEpidermal Growth FactorEpitheliumExtensive NecrosisFamily memberGastrointestinal DiseasesGene ProteinsGenesGoalsGrowth FactorHeparin BindingHomeostasisHumanHuman MilkHypoxiaIn VitroIncidenceInfantInflammatoryInjuryIntestinesLaboratoriesLiverMediatingMilkModalityModelingMolecularMorbidity - disease rateMothersMusNecrosisNecrotizing EnterocolitisNeonatalOnset of illnessPathogenesisPathway interactionsPatientsPeptidesPersonal SatisfactionPregnancyPremature InfantPropertyProphylactic treatmentRattusRegulationReportingResearch PersonnelRiskRoleRouteSeveritiesSignal PathwaySignal TransductionSignaling MoleculeSimulateSiteStagingSupplementationTestingTherapeuticTimeUnited StatesWeekbile acid transportercytokinecytotoxicexperiencefeedingheparin-binding EGF-like growth factorileuminhibitor/antagonistinjuredintestinal epitheliummortalityprogramsprotective effectprotein expression
项目摘要
DESCRIPTION (provided by applicant): Necrotizing enterocolitis (NEC) is a major cause of morbidity and mortality in premature infants but the cause is unknown and there are no effective treatments. Using the rat model of NEC, we reported that epidermal growth factor (EGF) markedly reduced the incidence and severity of NEC. The central goal of this proposal is to clarify the molecular mechanism(s) of EGF-mediated reduction of NEC. Accelerated intestinal apoptosis has been shown in patients with NEC, and EGF can protect cells from apoptosis. Our preliminary studies indicate that EGF treatment of NEC regulates pro-survival signaling molecules in the site of NEC injury. Specific Aim 1 will clarify which pro-survival pathways are regulated by EGF treatment of NEC by evaluating EGF treatment (a) on pro-survival and pro-apoptotic genes and proteins in the ileum of neonatal rats with NEC, (b) in waved-2 mice (aberrant EGF-R signaling under non-pathogenic circumstances), (c) in intestinal cell lines where crucial pro-survival and pro-apoptotic genes are over-expressed or blocked and (d) in neonatal rats given EGF-R signaling inhibitors. Recently, we have shown a crucial role of enterohepatic circulation in NEC pathogenesis. Our preliminary data indicate that administration of EGF to neonatal rats with NEC down-regulates luminal bile acid (BA) levels and regulates BA transporters, suggesting an important role of EGF in BA homeostasis. In Specific Aim 2, we will explore the mechanism by which EGF regulates BA transport in the intestine during NEC by evaluating EGF-mediated changes in (a) BA transport in neonatal rats with NEC, (b) IEC lines where essential components of BA transport are over-expressed or blocked, and (c) in waved-2 mice. Heparin-binding EGF-like growth factor (HB-EGF) is a member of the family of EGF-related peptides. Our preliminary results show that HB-EGF reduces the incidence of experimental NEC and enhances EGF-mediated reduction of NEC. Thus, HB-EGF with EGF may provide better protection against NEC through unique nonantagonistic mechanisms. Specific Aim 3 will examine the mechanisms of HB-EGF-mediated reduction of NEC by (a) identifying the optimal route and dose to reduce NEC in neonatal rats, (b) determining the optimal combination of EGF and HB-EGF to reduce NEC, and (c) utilizing an in vitro intestinal injury model to evaluate mechanisms of HB-EGF-mediated reduction of NEC. These studies will elucidate the mechanisms of EGF-mediated reduction of NEC, information that is essential to initiate use of EGF as a preventative or treatment modality for human NEC.
描述(由申请方提供):坏死性小肠结肠炎(NEC)是早产儿发病和死亡的主要原因,但原因不明,也没有有效的治疗方法。采用大鼠NEC模型,我们报道了表皮生长因子(EGF)明显降低NEC的发生率和严重程度。该建议的中心目标是阐明EGF介导的NEC减少的分子机制。NEC患者的肠道细胞凋亡加速,EGF可以保护细胞免于凋亡。我们的初步研究表明,EGF治疗NEC可以调节NEC损伤部位的促生存信号分子。具体目标1将通过评价EGF治疗(a)NEC新生大鼠回肠中促存活和促凋亡基因和蛋白,(B)wave-2小鼠中EGF治疗来阐明哪些促存活途径受NEC EGF治疗的调节(在非致病性情况下的异常EGF-R信号传导),(c)在肠细胞系中,其中关键的促存活和促凋亡基因过表达或被阻断,以及(d)在给予EGF-R信号传导抑制剂的新生大鼠中。最近,我们发现肠肝循环在NEC的发病机制中起着至关重要的作用。我们的初步数据表明,管理EGF的新生大鼠NEC下调管腔胆汁酸(BA)的水平和调节BA转运,这表明了重要的作用,EGF在BA的稳态。在具体目标2中,我们将探讨机制,EGF调节BA运输在肠NEC期间通过评估EGF介导的变化(a)BA运输在新生大鼠NEC,(B)IEC线,其中BA运输的基本组成部分被过度表达或阻断,(c)在波浪-2小鼠。肝素结合EGF样生长因子(HB-EGF)是EGF相关肽家族的成员。我们的初步结果表明,HB-EGF降低了实验性NEC的发病率,并增强了EGF介导的NEC的减少。因此,HB-EGF与EGF可以通过独特的非拮抗机制提供更好的保护作用。具体目标3将通过(a)鉴定在新生大鼠中降低NEC的最佳途径和剂量,(B)确定降低NEC的EGF和HB-EGF的最佳组合,和(c)利用体外肠损伤模型来评估HB-EGF介导的NEC降低的机制,来检查HB-EGF介导的NEC降低的机制。这些研究将阐明EGF介导的NEC减少的机制,这些信息对于开始使用EGF作为人类NEC的预防或治疗方式至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BOHUSLAV DVORAK其他文献
BOHUSLAV DVORAK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BOHUSLAV DVORAK', 18)}}的其他基金
Role of IL-18 and TNF-a in Necrotizing Enterocolitis
IL-18 和 TNF-a 在坏死性小肠结肠炎中的作用
- 批准号:
6935348 - 财政年份:2004
- 资助金额:
$ 29.11万 - 项目类别:
Role of IL-18 and TNF-a in Necrotizing Enterocolitis
IL-18 和 TNF-a 在坏死性小肠结肠炎中的作用
- 批准号:
6807093 - 财政年份:2004
- 资助金额:
$ 29.11万 - 项目类别:
Development of a Model of Necrotizing Enterocolitis
坏死性小肠结肠炎模型的建立
- 批准号:
6941196 - 财政年份:2004
- 资助金额:
$ 29.11万 - 项目类别:
Development of a Model of Necrotizing Enterocolitis
坏死性小肠结肠炎模型的建立
- 批准号:
6807773 - 财政年份:2004
- 资助金额:
$ 29.11万 - 项目类别:
EGF IN NEONATAL NECROTIZING ENTEROCOLITIS
EGF 在新生儿坏死性小肠结肠炎中的作用
- 批准号:
6224356 - 财政年份:2001
- 资助金额:
$ 29.11万 - 项目类别:
EGF IN NEONATAL NECROTIZING ENTEROCOLITIS
EGF 在新生儿坏死性小肠结肠炎中的作用
- 批准号:
6722925 - 财政年份:2001
- 资助金额:
$ 29.11万 - 项目类别:
EGF IN NEONATAL NECROTIZING ENTEROCOLITIS
EGF 在新生儿坏死性小肠结肠炎中的作用
- 批准号:
6629135 - 财政年份:2001
- 资助金额:
$ 29.11万 - 项目类别:
相似国自然基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
- 批准号:22007039
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
- 批准号:21372217
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
- 批准号:21172061
- 批准年份:2011
- 资助金额:30.0 万元
- 项目类别:面上项目
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
- 批准号:21176225
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
- 批准号:81072511
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
- 批准号:30660215
- 批准年份:2006
- 资助金额:21.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Lipid nanoparticle-mediated Inhalation delivery of anti-viral nucleic acids
脂质纳米颗粒介导的抗病毒核酸的吸入递送
- 批准号:
502577 - 财政年份:2024
- 资助金额:
$ 29.11万 - 项目类别:
CAREER: Highly Rapid and Sensitive Nanomechanoelectrical Detection of Nucleic Acids
职业:高度快速、灵敏的核酸纳米机电检测
- 批准号:
2338857 - 财政年份:2024
- 资助金额:
$ 29.11万 - 项目类别:
Continuing Grant
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 29.11万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 29.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Synthetic analogues based on metabolites of omega-3 fatty acids protect mitochondria in aging hearts
基于 omega-3 脂肪酸代谢物的合成类似物可保护衰老心脏中的线粒体
- 批准号:
477891 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Operating Grants
Metabolomic profiles of responders and non-responders to an omega-3 fatty acids supplementation.
对 omega-3 脂肪酸补充剂有反应和无反应者的代谢组学特征。
- 批准号:
495594 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrated understanding and manipulation of hypoxic cellular functions by artificial nucleic acids with hypoxia-accumulating properties
具有缺氧累积特性的人工核酸对缺氧细胞功能的综合理解和操纵
- 批准号:
23H02086 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)